MedAir Labs CEO discusses startup’s innovative technology at USPTO’s Invention-Con

The company’s rapid antigen test kit tests for multiple viruses with results in 10-15 minutes

CLEVE-LAND, August 9, 2022 /PRNewswire/ — President and CEO of MedAir Labs, Dr. William Kedia will discuss them Solon, Ohio-based startups innovative rapid antigen test kit at this year’s virtual Invention-Con: Inspiring and Redefining the Innovative Mindset, the annual United States Trademark and Patent Office (USPTO) conference for independent inventors, entrepreneurs and small business owners. Kedia will participate in a panel discussion along with three other innovative leaders August 11th to share how they are using technology to drive positive change.

MedAir Labs Rapid Antigen Test Kit tests for multiple viruses—including COVID-19—with a nasal swab with accuracy that rivals a PCR test, and results are available in 10 to 15 minutes. According to Kedia, the test kit’s superior sensitivity and specificity will effectively reduce diagnostic costs and improve patient experience.

“I am grateful to have been invited to attend such a prestigious conference and to join this exclusive inventor class recognized by the USPTO for driving innovation for humanity,” said Kedia. “I believe it is a testament to the disruptive nature of MedAir Labs’ innovative products, and I look forward to sharing with you how we inspire innovation in healthcare and life sciences.”

The company plans to submit an application for approval of the kit to the U.S. Food and Drug Administration by the end of August.

“Our rapid antigen test kit is a game changer,” said Kedia. “The way it was developed and its phenomenal accuracy with results delivered in such a short time frame make it truly unique.”

MedAir Labs plans to commercialize the innovation as a point-of-care test, initially administered in physician’s offices, emergency centers and emergency rooms, with plans to offer it over-the-counter in the future.

The idea of ​​creating a startup focused on developing innovative health technologies to improve people’s quality of life was born in early 2020 during a fire pit conversation at the height of the COVID-19 pandemic.

MedAir Labs, co-founded by Kedia, Murthy Talasila and Sonny Vermawas created to develop more accurate, effective and less intrusive solutions in support of the global health crisis.

Kedia served as the President of Family Medical Care Plus as a primary care physician, with offices in hudson and Tallmadgeout March 2002 until February of this year, when he sold the practice to focus on his role at MedAir Labs.

“The company was born out of my first experiences with patients during the pandemic,” Kedia said. “Our company is based on the accurate diagnosis and prevention of diseases. We are still in the start-up phase, but we are excited to see what is on the horizon.”

MedAir Labs first attracted attention and awards for its product Serenio. To learn more, visit Serenio.com.

For more information and to register to attend USPTO’s 2022 Invention-Con, visit uspto.gov/about-us/events. To learn more about MedAir Labs and its products, visit MedAirLabs.com.

About MedAir Labs

MedAir Labs is a life sciences startup based in Solon, Ohio, which aims to spur innovation in healthcare and life sciences by enhancing people’s experiences through a people-centric approach to design. The company was formed during the height of the COVID-19 pandemic in 2020 to develop meaningful diagnostic and therapeutic solutions in support of the global health crisis. As part of its mission, MedAir Labs has invested significant resources in the development of Serenio, a revolutionary patented technology that neutralizes airborne and surface coronaviruses, including COVID-19; antiviral personal protective equipment (PPE) solutions; and advanced triple antigen test kits.

CONTACT:

Murthy Talasila
216-338-2674
[email protected]

Bhuvana Krishnan
770-317-1895
[email protected]

SOURCE MedAir Labs

Leave a Comment

Your email address will not be published.